North America

The Blue Cross Blue Shield Association and others say they have agreed to invest in a nonprofit’s effort to develop and sell cheaper drugs.

Americans are having to choose between paying their mortgage and paying for insulin.

To ensure the ongoing affordability of generic medications for Americans, BCBS is committing $55 million to establish a partnership with Civica Rx to reduce costs of generics for consumers.

No bill was too small to get PhRMA’s attention.

State and federal spending on prescription drugs is dramatically outpacing inflation, even after accounting for rebates, according to a new analysis of federal data.

State health leaders trying to reduce the number of people dying from overdoses.

Insulin is not an optional medication for diabetics. Despite little change in production costs, the price of insulin has continued to rise.

A proposal to import prescription drugs from Canada to New Hampshire attracted bipartisan support at the Statehouse.

Suit didn’t show McKesson participated in price fixing, judge says.

A generic version of Copaxone, one of the most popular drugs to treat multiple sclerosis, didn't do much to lower costs for patients.

Hit hard by the opioid crisis, West Virginia is now also contending with a child welfare crisis.

More than half a million Kentuckians have diabetes and many of them depend on insulin every day just to stay alive.

Sometimes, the approval of a new generic drug offers more hype than hope.

At a recent healthcare conference, the CEO of a major hospital corporation mentioned the fact that the healthcare industry was the number 1 culprit for causing personal bankruptcies in the US - but it was ok because their profits are better than ever.

New bill (Senate bill 69) passed into law maybe a relief for diabetes patients.